Market Closed -
Singapore S.E.
05:15:13 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
0.255
SGD
|
0.00%
|
|
+2.00%
|
-3.77%
|
Fiscal Period: December |
2019
|
2020
|
2022
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
793.7
|
189.7
|
535.2
|
530.8
|
-
|
-
|
Enterprise Value (EV)
1 |
793.7
|
189.7
|
535.2
|
923.8
|
921.8
|
919.8
|
P/E ratio
|
17.3
x
|
-0.53
x
|
16.7
x
|
-
|
-
|
-
|
Yield
|
8.64%
|
17.7%
|
-
|
9.41%
|
10%
|
10.7%
|
Capitalization / Revenue
|
6.88
x
|
2.38
x
|
-
|
5.1
x
|
4.87
x
|
4.7
x
|
EV / Revenue
|
6.88
x
|
2.38
x
|
-
|
8.88
x
|
8.46
x
|
8.14
x
|
EV / EBITDA
|
7,932,023
x
|
3,062,734
x
|
-
|
-
|
-
|
-
|
EV / FCF
|
8,027,248
x
|
3,795,768
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
-
|
-
|
-
|
-
|
Price to Book
|
0.93
x
|
0.41
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
797,675
|
807,206
|
2,058,581
|
2,081,504
|
-
|
-
|
Reference price
2 |
0.9950
|
0.2350
|
0.2600
|
0.2550
|
0.2550
|
0.2550
|
Announcement Date
|
1/29/20
|
1/14/21
|
3/28/23
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2022
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
115.3
|
79.62
|
-
|
104
|
109
|
113
|
EBITDA
|
100.1
|
61.94
|
-
|
-
|
-
|
-
|
EBIT
|
100.1
|
61.94
|
-
|
-
|
-
|
-
|
Operating Margin
|
86.79%
|
77.79%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
75.39
|
-358.2
|
-
|
-
|
-
|
-
|
Net income
|
48.92
|
-352.4
|
33.58
|
-
|
-
|
-
|
Net margin
|
42.43%
|
-442.62%
|
-
|
-
|
-
|
-
|
EPS
|
0.0574
|
-0.4433
|
0.0156
|
-
|
-
|
-
|
Free Cash Flow
|
98.87
|
49.98
|
-
|
-
|
-
|
-
|
FCF margin
|
85.76%
|
62.77%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
98.81%
|
80.69%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
202.13%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0860
|
0.0415
|
-
|
0.0240
|
0.0256
|
0.0272
|
Announcement Date
|
1/29/20
|
1/14/21
|
3/28/23
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2022
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
393
|
391
|
389
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
98.9
|
50
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
6.17%
|
6.79%
|
-
|
15.5%
|
16.7%
|
17.9%
|
ROA (Net income/ Total Assets)
|
3.41%
|
3.68%
|
-
|
8%
|
8.7%
|
9.3%
|
Assets
|
1,433
|
-9,564
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
1.070
|
0.5700
|
-
|
-
|
-
|
-
|
Cash Flow per Share
2 |
-
|
-
|
-
|
0.0300
|
0.0300
|
0.0300
|
Capex
1 |
-
|
-
|
-
|
2.1
|
2.2
|
2.3
|
Capex / Sales
|
-
|
-
|
-
|
2.02%
|
2.02%
|
2.04%
|
Announcement Date
|
1/29/20
|
1/14/21
|
3/28/23
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -3.77% | 390M | | +4.62% | 55.76B | | -11.72% | 17.72B | | -5.05% | 13.23B | | +1.40% | 7.68B | | -16.54% | 5.39B | | +8.62% | 3.28B | | -2.31% | 3.23B | | -5.42% | 3.06B | | -8.15% | 2.73B |
Healthcare REITs
|